🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,609 results for “AB” Clear

  1. Basiliximab

    The First People's Hospital of Lianyungang

    Safety and Efficacy

    approved small molecule active

    1 trial

  2. Basiliximab,

    The First People's Hospital of Lianyungang

    Beta-Thalassemia Major

    approved small molecule completed

    1 trial

  3. Behavioral Intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    approved other completed

    1 trial

  4. Bempedoic Acid / Ezetimibe Oral Tablet

    Esperion Therapeutics

    Cardiovascular Diseases

    approved small molecule active

    1 trial

  5. Bempedoic Acid 180 MG Oral Tablet

    Esperion Therapeutics

    Healthy Lactating Women

    approved small molecule completed

    1 trial

  6. Berberine

    The First People's Hospital of Lianyungang

    Diabetes Mellitus

    approved small molecule completed

    1 trial

  7. Betadine bucal 100 mg/ml solución bucal, Agua oxigenada Foret 3 % solución cutánea y concentrado para solución bucal, Agua para preparaciones inyectables Meinsol, disolvente para uso parenteral

    The George Institute

    Respiratory diseases

    approved small molecule active

    1 trial

  8. Bevacizumab

    Arrowhead Pharmaceuticals Ireland Limited

    Pterygium

    approved small molecule completed

    1 trial

  9. Biktarvy 50 mg/200 mg/25 mg film-coated tablets

    Gilead Sciences Pty Limited

    HIV-1 infection

    approved small molecule active

    1 trial

  10. Biktarvy 50 mg/200 mg/25 mg film-coated tablets, Descovy 200 mg/25 mg film-coated tablets, Delstrigo 100 mg/300 mg/245 mg film-coated tablets, Pifeltro 100 mg film-coated tablets

    MEDA Pharma GmbH & Co. KG

    Human Immunodeficiency Virus

    approved small molecule active

    1 trial

  11. Bilaxten Flas 10 mg comprimidos bucodispersables

    A. Menarini Industrie Farmaceutiche Riunite s.r.l.

    Allergic rhinoconjunctivitis

    approved small molecule active

    1 trial

  12. Blinatumomab

    The First People's Hospital of Lianyungang

    Acute B-cell Lymphoblastic Leukemia

    approved small molecule active

    1 trial

  13. Blood Glucose Meter Systems

    Universal Integrated

    Diabetes

    approved other completed

    1 trial

  14. Braftovi 50 mg hard capsules, Zelboraf 240 mg film-coated tablets, Encorafenib, Erbitux 5 mg/mL solution for infusion, PEMBROLIZUMAB, Braftovi 75 mg hard capsules, Braftovi 75 mg hard capsules, Braftovi 50 mg hard capsules, Ribociclib, Ribociclib, NIVOLUMAB, Mektovi 15 mg film-coated tablets, Mektovi 15 mg film-coated tablets, Ribociclib

    Pfizer Australia Pty Ltd

    Solid tumors

    approved small molecule active

    1 trial

  15. Breeze2 glucometer

    Hospital Authority, Hong Kong

    Diabetes

    approved other active

    1 trial

  16. Brentuximab vedotin

    Takeda

    T-Cell Lymphoma

    approved small molecule completed

    1 trial

  17. Brentuximab vedotin

    Takeda

    Lymphoma

    approved small molecule active

    2 trials

  18. Brilique 90 mg film-coated tablets, Clopidogrel Medreg 75 mg filmom obalené tablety

    Disc Medicine

    Patients with coronary artery disease and an indication for PCI

    approved small molecule active

    1 trial

  19. Brixadi (Injectable Buprenorphine)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    1 trial

  20. Brodalumab 70 mg, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP, without the active substance., Kyntheum 210 mg solution for injection in pre-filled syringe

    LEO Pharma A/S

    Moderate-to-severe plaque psoriasis and a body weight ≥120 kg.

    approved small molecule active

    1 trial

  21. Brolucizumab

    The University of Hong Kong

    Age-Related Macular Degeneration

    approved small molecule completed

    1 trial

  22. Bubble-Enhanced FAST (BEFAST)

    United Therapeutics Europe Ltd

    Abdominal Trauma

    approved small molecule completed

    1 trial

  23. Bupivacaine liposome injectable suspension

    Heron Therapeutics

    Analgesia

    approved small molecule completed

    1 trial

  24. Bupivacaine liposome injectable suspension (IPSA block)

    Pacira Ireland Limited

    Total Knee Arthroplasty

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources